2023 annual financial data
Capricor Therapeutics 2023 Net margin
Direct answer
Net margin was -88.52%.
Operating income was -24,077,859 USD and net income was -22,287,542 USD.
Operating cash flow was -25,596,545 USD.
Get free Capricor Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 25,178,066 USD
- Operating income
- -24,077,859 USD
- Net income
- -22,287,542 USD
- Operating cash flow
- -25,596,545 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Capricor Therapeutics financial years